Fig. 4 (abstract P793).From: 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019): part 2Anti-PD-L1 Reduces ALPN-202-Mediated Anti-Tumor ActivityBack to article page
